127 related articles for article (PubMed ID: 36154668)
1. Establishment of the removal method of undifferentiated induced pluripotent stem cells coexisting with chondrocytes using R-17F antibody.
Miyazaki T; Hanamatsu H; Onodera T; Furukawa JI; Xu L; Homan K; Baba R; Kawasaki T; Iwasaki N
Regen Med; 2022 Nov; 17(11):793-803. PubMed ID: 36154668
[No Abstract] [Full Text] [Related]
2. Evaluation of Residual Human-Induced Pluripotent Stem Cells in Human Chondrocytes by Cell Type-Specific Glycosphingolipid Glycome Analysis Based on the Aminolysis-SALSA Technique.
Miyazaki T; Hanamatsu H; Xu L; Onodera T; Furukawa JI; Homan K; Baba R; Kawasaki T; Iwasaki N
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905707
[TBL] [Abstract][Full Text] [Related]
3. Alterations of Glycosphingolipid Glycans and Chondrogenic Markers during Differentiation of Human Induced Pluripotent Stem Cells into Chondrocytes.
Xu L; Hanamatsu H; Homan K; Onodera T; Miyazaki T; Furukawa JI; Hontani K; Tian Y; Baba R; Iwasaki N
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33271874
[TBL] [Abstract][Full Text] [Related]
4. A Cytotoxic Antibody Recognizing Lacto-N-fucopentaose I (LNFP I) on Human Induced Pluripotent Stem (hiPS) Cells.
Matsumoto S; Nakao H; Kawabe K; Nonaka M; Toyoda H; Takishima Y; Kawabata K; Yamaguchi T; Furue MK; Taki T; Okumura T; Yamazaki Y; Nakaya S; Kawasaki N; Kawasaki T
J Biol Chem; 2015 Aug; 290(33):20071-85. PubMed ID: 26100630
[TBL] [Abstract][Full Text] [Related]
5. An Ethanol Extract of
Kim A; Baek SJ; Shin S; Lee SY; Chung SK
Nutrients; 2023 May; 15(10):. PubMed ID: 37242247
[TBL] [Abstract][Full Text] [Related]
6. Ethanol extract of Magnoliae cortex (EEMC) limits teratoma formation of pluripotent stem cells by selective elimination of undifferentiated cells through the p53-dependent mitochondrial apoptotic pathway.
Kim A; Lee SY; Seo CS; Chung SK
Phytomedicine; 2020 Apr; 69():153198. PubMed ID: 32151917
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
8. Treating iPSC-Derived β Cells with an Anti-CD30 Antibody-Drug Conjugate Eliminates the Risk of Teratoma Development upon Transplantation.
Pellegrini S; Zamarian V; Landi E; Cospito A; Lombardo MT; Manenti F; Citro A; Schiavo Lena M; Piemonti L; Sordi V
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077097
[TBL] [Abstract][Full Text] [Related]
9. Generation of rat induced pluripotent stem cells using a plasmid vector and possible application of a keratan sulfate glycan recognizing antibody in discriminating teratoma formation phenotypes.
Makanga JO; Kobayashi M; Ikeda H; Christianto A; Toyoda H; Yamada M; Kawasaki T; Inazu T
Biol Pharm Bull; 2015; 38(1):127-33. PubMed ID: 25744468
[TBL] [Abstract][Full Text] [Related]
10. Morphological Analysis of Live Undifferentiated Cells Derived from Induced Pluripotent Stem Cells.
Osawa Y; Miyamoto T; Ohno S; Ohno E
Stem Cells Dev; 2018 Jan; 27(1):1-9. PubMed ID: 28978257
[TBL] [Abstract][Full Text] [Related]
11. The tumourigenicity of iPS cells and their differentiated derivates.
Liu Z; Tang Y; Lü S; Zhou J; Du Z; Duan C; Li Z; Wang C
J Cell Mol Med; 2013 Jun; 17(6):782-91. PubMed ID: 23711115
[TBL] [Abstract][Full Text] [Related]
12. Paracrine Interactions Involved in Human Induced Pluripotent Stem Cells Differentiation into Chondrocytes.
Zhao Y; Liu H; Zhao C; Dang P; Li H; Farzaneh M
Curr Stem Cell Res Ther; 2020; 15(3):233-242. PubMed ID: 31889496
[TBL] [Abstract][Full Text] [Related]
13. Caffeic acid selectively eliminates teratogenic human-induced pluripotent stem cells via apoptotic cell death.
Kim A; Lee SY; Chung SK
Phytomedicine; 2022 Jul; 102():154144. PubMed ID: 35537368
[TBL] [Abstract][Full Text] [Related]
14. Direct
Xiang M; Lu M; Quan J; Xu M; Meng D; Cui A; Li N; Liu Y; Lu P; Kang X; Wang X; Sun N; Zhao M; Liang Q; Le L; Wang X; Zhang J; Chen S
Theranostics; 2019; 9(1):290-310. PubMed ID: 30662568
[TBL] [Abstract][Full Text] [Related]
15. Teratoma Formation Assay for Assessing Pluripotency and Tumorigenicity of Pluripotent Stem Cells.
Miyawaki S; Okada Y; Okano H; Miura K
Bio Protoc; 2017 Aug; 7(16):e2518. PubMed ID: 34541178
[TBL] [Abstract][Full Text] [Related]
16. Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules.
Dressel R; Guan K; Nolte J; Elsner L; Monecke S; Nayernia K; Hasenfuss G; Engel W
Biol Direct; 2009 Aug; 4():31. PubMed ID: 19715575
[TBL] [Abstract][Full Text] [Related]
17. A lithium-containing biomaterial promotes chondrogenic differentiation of induced pluripotent stem cells with reducing hypertrophy.
Hu Y; Chen L; Gao Y; Cheng P; Yang L; Wu C; Jie Q
Stem Cell Res Ther; 2020 Feb; 11(1):77. PubMed ID: 32085810
[TBL] [Abstract][Full Text] [Related]
18. Residual undifferentiated cells during differentiation of induced pluripotent stem cells in vitro and in vivo.
Fu W; Wang SJ; Zhou GD; Liu W; Cao Y; Zhang WJ
Stem Cells Dev; 2012 Mar; 21(4):521-9. PubMed ID: 21631153
[TBL] [Abstract][Full Text] [Related]
19. Rapid generation of secondary fibroblasts through teratoma formation.
Cho SM; Park JS; Min B; Kwon S; Kang YK
Biotechniques; 2015 Jul; 59(1):34-41. PubMed ID: 26156782
[TBL] [Abstract][Full Text] [Related]
20. No Tumorigenicity of Allogeneic Induced Pluripotent Stem Cells in Major Histocompatibility Complex-matched Cynomolgus Macaques.
Ishigaki H; Pham VL; Terai J; Sasamura T; Nguyen CT; Ishida H; Okahara J; Kaneko S; Shiina T; Nakayama M; Itoh Y; Ogasawara K
Cell Transplant; 2021; 30():963689721992066. PubMed ID: 33588604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
